Renal denervation for resistant hypertension-the Symplicity HTN-1 study

被引：3
|
作者：
O'Brien, Eoin [1 ]
机构：
[1] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland
来源：
LANCET | 2014年 / 383卷 / 9932期
关键词：
D O I：
10.1016/S0140-6736(14)60910-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1884 / 1884
页数：1
相关论文
共 50 条
  • [1] Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study
    Krum, Henry
    Schlaich, Markus P.
    Sobotka, Paul A.
    Boehm, Michael
    Mahfoud, Felix
    Rocha-Singh, Krishna
    Katholi, Richard
    Esler, Murray D.
    [J]. LANCET, 2014, 383 (9917): : 622 - 629
  • [2] Benefits of renal denervation persist at 3 years—data from Symplicity HTN-1
    [J]. Nature Reviews Cardiology, 2014, 11 (1) : 2 - 2
  • [3] Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study (vol 383, pg 622, 2014)
    Krum, H.
    Schlaich, M. P.
    Boehm, M.
    [J]. LANCET, 2014, 383 (9917): : 602 - 602
  • [4] Resistant Hypertension and Renal Denervation. Considerations on the Results of the Symplicity HTN-3 Trial
    Ruilope, Luis M.
    Arribas, Fernando
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2014, 67 (11): : 881 - 882
  • [5] Catheter-Based Renal Denervation for Resistant Hypertension: Rationale and Design of the SYMPLICITY HTN-3 Trial
    Kandzari, David E.
    Bhatt, Deepak L.
    Sobotka, Paul A.
    O'Neill, William W.
    Esler, Murray
    Flack, John M.
    Katzen, Barry T.
    Leon, Martin B.
    Massaro, Joseph M.
    Negoita, Manuela
    Oparil, Suzanne
    Rocha-Singh, Krishna
    Straley, Craig
    Townsend, Raymond R.
    Bakris, George
    [J]. CLINICAL CARDIOLOGY, 2012, 35 (09) : 528 - 535
  • [6] Opinion of the German Society of Cardiology on the Symplicity HTN-3 Study in Patients with resistant Arterial Hypertension after Renal Denervation
    Boehm, M.
    Hamm, C. W.
    Kuck, K. -H.
    Ertl, G.
    Mahfoud, F.
    Schunkert, H.
    [J]. KARDIOLOGE, 2014, 8 (03): : 244 - 245
  • [7] Renal denervation in treatment-resistant hypertension - Oslo RDN, Symplicity HTN-3 and INSPiRED randomized trials
    Kjeldsen, Sverre E.
    Narkiewicz, Krzysztof
    Oparil, Suzanne
    Hedner, Thomas
    [J]. BLOOD PRESSURE, 2014, 23 (03) : 135 - 137
  • [8] Renal sympathetic denervation in the aftermath of Symplicity HTN-3
    Kjeldsen, Sverre E.
    Elmula, Fadl E. M. Fadl
    Persu, Alexandre
    Jin, Yu
    Staessen, Jan A.
    [J]. BLOOD PRESSURE, 2014, 23 (05) : 256 - 261
  • [9] Renal Denervation after Symplicity HTN-3: An Update
    Alexandre Persu
    Yu Jin
    Fadl Elmula Mohamed Fadl Elmula
    Lotte Jacobs
    Jean Renkin
    Sverre Kjeldsen
    [J]. Current Hypertension Reports, 2014, 16
  • [10] PREFERENTIAL REDUCTION IN MORNING/NOCTURNAL HYPERTENSION BY RENAL DENERVATION FOR DRUG-RESISTANT HYPERTENSION: A NEW ABPM ANALYSIS OF SYMPLICITY HTN-3 AND HTN-JAPAN
    Kario, K.
    Bakris, G. L.
    Bhatt, D.
    [J]. JOURNAL OF HYPERTENSION, 2015, 33 : E52 - E52
12345